Medication reconciliation on discharge in a tertiary care Riyadh Hospital: An observational study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
20
05
2021
accepted:
22
02
2022
entrez:
15
3
2022
pubmed:
16
3
2022
medline:
4
5
2022
Statut:
epublish
Résumé
The purpose of this study was to assess the frequency and characteristics of discharge medication discrepancies as identified by pharmacists during discharge medication reconciliation. We also attempted to identify the factors that influence the occurrence of drug discrepancies during medication reconciliation. From June to December 2019, a prospective study was performed at the cardiac center of King Fahad Medical City (KFMC), a tertiary care hospital in Riyadh. The information from discharge prescriptions as compared to the medication administration record (MAR), medication history in the cortex system, and the patient home medication list collected from the medication reconciliation form on admission. The study included all adult patients discharged from KFMC's cardiac center. These participants comprised 776 patients, 64.6 percent of whom were men and 35.4 percent of whom were women. Medication discrepancies were encountered in 180 patients (23.2%) out of 776 patients. In regards to the number of discharged medications, 651(83.9%) patients had ≥ 5 medications. Around, 174 (73.4%) discrepancies were intentional, and 63 (26.6%) were unintentional discrepancies. The risk of unintentional medication discrepancy was increased with an increasing number of medications (P-value = 0.008). One out of every four cardiac patients discharged from our hospital had at least one medication discrepancy. The number of drugs taken and the number of discrepancies was found to be related. Necessary steps should be taken to reduce these discrepancies and improve the standard of care.
Identifiants
pubmed: 35290378
doi: 10.1371/journal.pone.0265042
pii: PONE-D-21-16702
pmc: PMC8923456
doi:
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0265042Commentaires et corrections
Type : ErratumIn
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
BMC Med Inform Decis Mak. 2016 Aug 22;16:112
pubmed: 27549581
Arch Intern Med. 2009 Nov 23;169(21):2003-10
pubmed: 19933963
Ann Pharmacother. 2008 Oct;42(10):1373-9
pubmed: 18780806
Int J Clin Pharm. 2018 Oct;40(5):1154-1164
pubmed: 29754251
PLoS One. 2021 Jun 23;16(6):e0253588
pubmed: 34161388
Arch Intern Med. 1993 Aug 23;153(16):1863-8
pubmed: 8250647
J Am Med Inform Assoc. 1996 May-Jun;3(3):234-44
pubmed: 8723614
Integr Pharm Res Pract. 2020 Oct 13;9:195-203
pubmed: 33117666
Am J Health Syst Pharm. 2009 Dec 1;66(23):2126-31
pubmed: 19923314
Br J Clin Pharmacol. 2011 Mar;71(3):449-57
pubmed: 21284705
Saudi Pharm J. 2011 Oct;19(4):263-7
pubmed: 23960767
Int J Clin Pharm. 2011 Jun;33(3):501-11
pubmed: 21442286
Saudi Pharm J. 2017 Nov;25(7):1082-1085
pubmed: 29158719
Pharmacotherapy. 1997 Jan-Feb;17(1):126-32
pubmed: 9017773
Pharm Pract (Granada). 2017 Jan-Mar;15(1):864
pubmed: 28503220